Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06937931 · ClinicalTrials.gov registry record · Phase 2

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

A Phase 2 study of Cervical Dystonia, sponsored by Ipsen.

Recruiting
Registry status
Phase 2
Development phase
132
Enrollment target
20
Study locations

NCT06937931 is a Phase 2 study of Cervical Dystonia that is actively recruiting participants, run by Ipsen. The registered enrollment target is 132 participants, above the 78-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (69% higher). The trial reports 20 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06937931, a Phase 2 study of Cervical Dystonia, is actively recruiting participants, sponsored by Ipsen.

RECRUITING
Registry status
Phase 2
Development phase
132 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the efficacy and safety of the study drug, IPN10200, and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain and stiffness, and headaches. CD is believed to involve deep parts within the brain that control movement, but genetic factors, environmental factors, and abnormalities in the brain may also play a role. The usual treatment for CD includes injecting BoNT into the affected muscles, but the treatment only lasts about 3 months. IPN10200 is designed to last for a longer period. The study will consist of two periods: 1. A Screening Period of up to 4 weeks (28 days) to assess whether a participant can take part in the study and requires at least one visit. 2. A Treatment Period of 36 weeks. On Day 1 of the treatment period, participants will receive either IPN10200 Dose A or Dose B (additional participants may receive IPN10200 Dose C) of the study drug, or placebo distributed into different muscles in the head, neck and shoulders. Participants may continue some other medications, but details need to be recorded. There will be 10 visits to the clinic in person and one remote visits (phone call) (12 visits to the clinic for participants who receive Dose C). Participants will undergo blood samplings, urine collections, physical/neurological examinations, and clinical evaluations. Participants will also need to complete questionnaires throughout the study. The total study duration for a participant will be up to 40 weeks (approximately 9 months).

Conditions Studied

Cervical Dystonia

Interventions

  • OTHER Placebo
  • BIOLOGICAL IPN10200

Study Locations (20)

Other

  • Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika - Brno
  • MINKSneuro s.r.o. - Brno
  • NEUROHK s.r.o. - Choceň
  • Fakultni nemocnice Olomouc - Neurologicka klinika - Olomouc
  • Vseobecna fakultni nemocnice v Praze - Neurologicka klinika - Prague
  • CHU Grenoble Alpes - Site Nord - Neurology - Grenoble
  • Timone University Hospital - Marseille
  • CHU Nimes - Hôpital Caremeau - Nîmes
  • Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie - Strasbourg
  • Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences) - Toulouse
  • Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie - Haag in Oberbayern

Florida

  • Parkinson's Ds & Mvt Disorders Cntr - Boca Raton
  • USF Health Byrd Alzheimer's Institute - Tampa

Arizona

  • University of Arizona Health Sciences - Neurology - Tucson

California

  • Parkinson's & Mvmt Disorders Inst - Fountain Valley

Georgia

  • Emory Brain Health Center - Atlanta

Illinois

  • Rush Medical Center - Chicago

Michigan

  • Quest Research Institute - Farmington Hills

New York

  • Ichan Sch of Medicine @ Mt. Sinai - New York

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2025-06-30
Est. Completion 2027-11-05
Phase Phase 2

Sponsor

Ipsen

85 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06937931

The ClinicalTrials.gov registry entry for NCT06937931 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 78-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (69% higher). The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Dystonia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06937931 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT06937931 about?

NCT06937931 is a clinical study titled "A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults". The purpose of this study is to evaluate the efficacy and safety of the study drug, IPN10200, and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain ...

What is the current status of trial NCT06937931?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2025-06-30. Estimated completion is 2027-11-05.

What conditions does trial NCT06937931 study?

This clinical trial studies the following conditions: Cervical Dystonia.

What interventions are being tested in trial NCT06937931?

The interventions under investigation include: Placebo (OTHER), IPN10200 (BIOLOGICAL).

Who is sponsoring clinical trial NCT06937931?

This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06937931 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervical Dystonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cervical Dystonia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.